New Zealand markets close in 6 hours 48 minutes

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.84-0.03 (-0.44%)
At close: 4:00PM EDT
6.81 -0.03 (-0.44%)
After hours: 05:12PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.87
Open6.94
Bid6.80 x 1200
Ask6.90 x 1800
Day's range6.76 - 7.01
52-week range3.50 - 24.90
Volume2,925,083
Avg. volume5,869,863
Market cap856.854M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
EPS (TTM)-0.48
Earnings date10 Nov 2021 - 15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est12.50
  • GlobeNewswire

    SHAREHOLDER ALERT: Morris Kandinov Investigating TSN, VXRT, APYX, and EHTH; Shareholders are Encouraged to Contact the Firm

    SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Tyson Foods, Inc., Vaxart, Inc., Apyx Medical Corporation, and eHealth, Inc. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 708-3993. Tyson Foods, Inc. (NYSE: TSN) Shareholder Rights Investigation Morris Kandinov is investigating Tyson Foods, Inc. regarding corporate governance failures, possible bre

  • Motley Fool

    Can This COVID Vaccine Stock Help Make You Rich?

    There are a handful of companies that dominate the coronavirus vaccine market. Vaccine hesitancy prevents many people from getting inoculated. One company looking to make headway into the vaccine-hesitant crowd is Vaxart (NASDAQ: VXRT).

  • Motley Fool

    Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?

    Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. The biotech company is developing a coronavirus-vaccine candidate in pill form. With 56% of Americans fully vaccinated, though, your question now may: Will Vaxart be too late to carve out market share?